SCHEMBL23930860

SCHEMBL23930860

COC(=O)c1c(F)ncn1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 2/20 0.38
APOBEC3G Q9HC16 2/20 0.38
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
FGFR1 P11362 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
HTR3A P46098 1/20 0.34
KDM4E B2RXH2 2/20 0.33
GRM5 P41594 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21721397 0.81 ALDH1A1 (0.39) POLBNPC1RAB9ANPSR1CA12
SCHEMBL23930969 0.81 GABRA1 (0.36) APOBEC3AAPOBEC3GALDH1A1TP53CYP1A2
SCHEMBL22697032 0.81 MAPK1 (0.43) APOBEC3AAPOBEC3GNPC1RAB9ACA12
SCHEMBL71364 0.79 APOBEC3A (0.46) APOBEC3AAPOBEC3GFGFR1NPSR1ALDH1A1
SCHEMBL21880074 0.79 APOBEC3A (0.41) APOBEC3AAPOBEC3GPOLBLMNAGRM5
SCHEMBL23992032 0.78 APOBEC3A (0.38) APOBEC3AAPOBEC3GNPC1RAB9AFGFR1
SCHEMBL23930914 0.78 APOBEC3A (0.38) APOBEC3AAPOBEC3GNPC1RAB9AFGFR1
SCHEMBL31333068 0.78 APOBEC3A (0.38) APOBEC3AAPOBEC3GRAB9AFGFR1NPSR1
SCHEMBL31332992 0.77 NPC1 (0.43) APOBEC3AAPOBEC3GNPC1ALDH1A1LMNA
SCHEMBL31332887 0.74 CYP11B1 (0.38) APOBEC3AAPOBEC3GFGFR1NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed